Susoctocog alfa, sold under the brand name Obizur, is a

medication Medication (also called medicament, medicine, pharmaceutical drug, medicinal product, medicinal drug or simply drug) is a drug used to medical diagnosis, diagnose, cure, treat, or preventive medicine, prevent disease. Drug therapy (pharmaco ...

used for the treatment of bleeding episodes in adults with acquired

haemophilia Haemophilia (British English), or hemophilia (American English) (), is a mostly inherited genetic disorder that impairs the body's ability to make blood clots, a process needed to stop bleeding. This results in people bleeding for a long ...

, a bleeding disorder caused by the spontaneous development of antibodies that inactivate

factor VIII Coagulation factor VIII (Factor VIII, FVIII, also known as anti-hemophilic factor (AHF)) is an essential blood clotting protein. In humans, it is encoded by ''F8'' gene. Defects in this gene result in hemophilia A, an X-linked bleeding disorder ...

. Susoctocog alfa was approved for medical use in the United States in October 2014, and for medical use in the European Union in November 2015. Factor VIII is one of the proteins needed for normal clotting of the blood.

References

Antihemorrhagics {{blood-drug-stub